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Background. Assessment of cardiac output (CO) by the FloTrac/VigileoTM system may offer a
less invasive means of determining the CO than either the pulmonary artery catheter (PAC)
or the PiCCOplusTM system. The aim of this study was to compare CO measurements made
using the FloTrac/VigileoTM system with upgraded software (FCO, Edwards Lifesciences, Irvine
CA, USA), the PiCCOplusTM system (PCO, Pulsion Medical Systems, Munich, Germany) and
continuous CO monitoring using a PAC (CCO; VigilanceTM monitoring, Edwards Lifesciences,
Irvine CA, USA) with intermittent pulmonary artery thermodilution (ICO). The study was
conducted in patients undergoing elective cardiac surgery.
Methods. Thirty-one patients with preserved left ventricular function were enrolled. CCO,
FCO, and PCO were recorded in the perioperative period at six predefined time points after
achieving stable haemodynamic conditions; ICO was determined from the mean of three bolus
injections. Bland–Altman analysis was used to compare CCO, FCO, and PCO with ICO.
Results. Bland–Altman analysis revealed a comparable mean bias and limits of agreement for
all tested continuous CO monitoring devices using ICO as reference method. Agreement for
all devices decreased in the postoperative period.
Conclusion. The performance of the FloTrac/VigileoTM system, the PiCCOplusTM, and the
VigilanceTM CCO monitoring for CO measurement were comparable when tested against
intermittent thermodilution in patients undergoing elective cardiac surgery.
Br J Anaesth 2007; 99: 329–36
Keywords: heart, cardiac output; measurement techniques, cardiac ouput; measurement
techniques, thermodilution
Accepted for publication: May 6, 2007
Cardiac output (CO) is monitored in critically ill patients to
assess cardiac function with the primary goal of maintaining
adequate tissue perfusion. In patients undergoing cardiac
surgery, thermodilution using a pulmonary artery catheter
(PAC) is still the most frequently applied technique.
However, the value of the PAC has been questioned in recent
years and its impact on outcome is a matter of debate;1–4
several less invasive techniques which avoid the risks associ-
ated with the PAC have become available for routine CO
monitoring.5 6 One of these is pulse contour analysis using
the PiCCOplusTM system (Pulsion Medical Systems,
Munich, Germany). This records aortic pressure waveforms
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using a thermistor-tipped catheter. The CO is calculated
using an algorithm based on the area under the systolic part
of the pressure waveform after calibration by transpulmonary
thermodilution.7 This calibration is also used to adjust for
individual vascular compliance. The system has extensively
been evaluated and most studies demonstrate adequate
results using the current device and software when compared
with pulmonary artery thermodilution.8–11
Recently, a new pulse wave analysis device that does not
require external calibration has become available.12 The
FloTrac/VigileoTM system (Edwards Lifesciences, Irvine,
CA, USA) obtains the pressure wave signal from any stan-
dard peripheral arterial line and the SD of pulse pressure is
empirically correlated to the stroke volume (SV) based on
patient characteristics (age, gender, body height, and weight)
after automatic adjustment for actual vascular compliance.
Early validation studies for this device showed conflicting
results.12–15 As a consequence, the FloTrac/VigileoTM soft-
ware with its underlying algorithm was improved and the
time window for vascular adjustment was reduced.
The aim of this study was to evaluate the accuracy of
CO measurements in patients undergoing elective cardiac
surgery; the CO was determined using four devices:
(1) the FloTrac/VigileoTM system with upgraded software
(FCO), (2) the PiCCOplusTM system (PCO), (3) continu-
ous CO monitoring using a PAC (CCO, in combination
with a VigilanceTM monitor, Edwards Lifesciences), and
(4) intermittent pulmonary artery thermodilution.
Methods
Patients and setting
Patients undergoing elective coronary artery bypass grafting
and/or valve surgery gave their informed consent to the
study, which was approved by the local Ethics Committee.
Exclusion criteria were reduced left and right ventricular
function (ejection fraction ,40%), preoperative dysrhyth-
mias, severe valve regurgitation, intracardiac shunts, pulmon-
ary artery hypertension, severe arterial occlusive disease, and
body weight ,40 kg. A sample size of 25 patients was
calculated on the basis of an expected difference of mean
values between CO determination by the continuous
measurement techniques and intermittent thermodilution of
0.3 litre min21 (a = 0.05 and power .0.9).
Routine perioperative management
Anaesthesia and postoperative management followed insti-
tutional standards. After tracheal intubation, the lungs
were ventilated using volume-controlled mode to maintain
normocarbia. In the postoperative period, the patients were
extubated in the intensive care unit after the completion of
the institutional weaning protocol. Routine monitoring
(Philips IntelliVueTM Monitoring, Philips Medical Systems,
Andover, MA, USA) during the entire perioperative period
included pulse oximetry, 5-lead ECG, invasive blood
pressure measurement via a peripheral radial arterial line,
and central venous and pulmonary capillary wedge pressures
(PCWPs) assessed by standard transducers (TruewaveTM PX,
Edwards Lifesciences). Postoperative pacing was used in all
patients in an AOO or DDD mode at a minimal rate of 80
beats min21. Haemodynamic therapy was guided by values
obtained from continuous CO monitoring using a PAC. I.v.
fluids and blood products (target hematocrit .25%), vasodi-
lators (nitroglycerine/phentolamine), and catecholamines
(norepinephrine/dobutamine) were used as appropriate to
achieve and maintain a mean arterial pressure (MAP) of
65–75 mm Hg and a cardiac index of .2 litre min21m22.
CO monitoring
After induction of anaesthesia, a 7.5 F PAC (Swan-Ganz
CCO/VIP PAC, Edwards Lifesciences) was introduced via
right internal jugular vein access and attached to a
VigilanceTM monitor (Version 6.3, Edwards Lifesciences).
A CO monitoring set with a closed cold injectate delivery
system (Edwards Lifesciences) used for intermittent ther-
modilution was connected to the proximal lumen of the
PAC.
A 4F thermistor-tipped arterial catheter (PulsiocathTM
thermodilution catheter) was inserted into the left femoral
artery, its tip advanced to the abdominal aorta, and con-
nected to the stand-alone PiCCOplusTM computer (Version
6.0; Pulsion Medical Systems). Continuous CO measurement
was initiated after the initial calibration of the system by a
triplicate 20 ml ice-cold normal saline injection through an
additional 7F central venous catheter (transpulmonary ther-
modilution). The calibration process was repeated according
to the manufacturer’s guidelines every 8 h.
A FloTracTM sensor kit was connected to the arterial line
and connected to the VigileoTM monitor programmed with
the 1.07 version of the software for this device (Edwards
Lifesciences). Patient data (age, gender, body weight, and
height) were entered and after checking the arterial line
waveform fidelity, the system was zeroed and CO measure-
ment initiated. The CO was recorded continuously for 24 h
except for a short period when the patient was transferred
from the operating room into the intensive care unit.
Pulse wave analysis algorithms
FloTrac/VigileoTM system
The algorithm uses the basic equation (1) for measuring
CO with heart rate (HR) being determined from the
pressure waveform through conventional methods:
CO ¼ HR  SV: ð1Þ
The calculation of SV can be divided into two parts
based on manually entered patient data (age, gender, body
length, and weight):
(1) The contribution of pulse pressure to SV, which is
proportional to the SD of arterial pulse pressure (SDap).
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(2) The influence of vascular resistance and compliance
on SV integrated into a single variable (x). Thus, CO
is calculated as follows (2):
CO ¼ HR : SDap  x: ð2Þ
Different characteristics of the blood pressure16 are
utilized in equation (3) for the derivation of x from a
multivariate regression model (M). These include
Langewouter’s aortic compliance (Cp),17 MAP, the vari-
ance, skewness, and kurtosis of the pressure wave curve.
Body surface area (BSA) also appears in the model.
Further details of this proprietary algorithm are not dis-
closed by Edwards Lifesciences.
x ¼ MðCp; MAP; variance; skewness; kurtosis; BSAÞ: ð3Þ
Pulse pressure is recorded at a frequency of 100 Hz and
SDap is determined during a window of 20 s. After the
early clinical experiences with this algorithm, the rate of
the adjustment of x was reduced from the initial interval
of 10 to 1 min in the latest version of the software.
PiCCOplusTM system
The basics of the PiCCOplusTM method and its underlying
algorithm have been described in detail elsewhere.7
Briefly, CO is calculated every 3 s by measuring the area
under the systolic part of the arterial pressure waveform
and dividing this area by the aortic impedance.18 For an
adjustment of individual aortic compliance, calibration by
transpulmonary thermodilution is required. Modification of
the algorithm enhanced accuracy by the additional analysis
of the shape of the pressure waveform.10
Study protocol
The CO data from all devices and standard haemodynamic
data (HR, MAP, central venous pressure, and PCWP) were
recorded by an observer not involved in the routine
management of the patient at predefined time points
before transpulmonary thermodilution measurements.
Transpulmonary thermodilution measurements were made
under stable haemodynamic conditions. Three injections
of iced NaCl 0.9% (10 ml, 4–68C) were made using a
closed cold injectate delivery system and the mean value
recorded. The measurements were free of interference from
surgery or infusion boluses. Predefined measurement points
were: T1¼after induction of anaesthesia (study initiation),
T2 ¼1 h post-initiation (after sternotomy), T3¼4 h post-
initiation (at skin closure), T4–6¼8, 12, and 24 h post-
initiation (after the transfer to the intensive care unit).
Statistics
Statistical analysis was done using StatVieww for
Windows version 5.01w (SAS Institute Inc., Cary, NC,
USA) and SPSS for Windows Release 12.0.2 (SPSS Inc.,
Chicago, IL, USA). The data were tested for normality
by the Kolmogorov–Smirnov test. ANOVA for repeated
measurements (Bonferroni–Dunn) was done to assess the
differences on haemodynamic variables between consecu-
tive measurements. Bland–Altman analyses19 and paired
t-tests were done to compare CO values obtained by the
different devices with CO assessed by intermittent pul-
monary artery thermodilution. Unless otherwise stated data
are presented as mean and SD.
Results
Thirty-one patients, mean age 67 (range 46–85 yr) yr, 26
male, BMI 28.2(5.3) kg m22 with preserved left ventricular
function [preoperative ejection fraction 62.4(12.2) %],
undergoing elective cardiac surgery were enrolled. All
patients were ASA physical status III and were in sinus
rhythm before the induction of anaesthesia. Eleven patients
(35%) underwent aortic valve replacement, one patient (3%)
underwent mitral valve replacement, three patients (10%)
underwent mitral valve reconstruction, three patients (10%)
underwent coronary artery bypass grafting, and 13 patients
(42%) underwent combined procedures.
The mean duration of mild hypothermic cardiopulmo-
nary bypass was 100(11) min, mean operation time was
261(48) min, and mean ICU stay was 2(1) days. The
measurement period was uneventful for all patients. After
the removal of the PiCCO catheter, one patient (3%)
developed arterial bleeding resulting in an inguino-scrotal
haematoma requiring surgical intervention.
There was a significant increase in HR and CO assessed
by all tested techniques during the observation period
(Table 1). Systemic vascular resistance significantly
decreased, whereas all other haemodynamic variables
(MAP, MPAP, CVP, and PCWP) showed no significant
changes over time.
CO assessed by the FloTrac/VigileoTM and the
PiCCOplusTM system was significantly higher for the first
two measurements when compared with CO assessed by
intermittent thermodilution. The CO values ranged between
2.4 and 7.5 litre min21 during the intraoperative period and
between 3.1 and 9.3 litre min21 in the postoperative period.
Bland–Altman analysis (Figures 1 and 2, Table 2)
revealed a consistently positive mean bias for the FloTrac/
VigileoTM system, the PiCCOplusTM system, and continu-
ous CO monitoring by the PAC when compared with the
intermittent pulmonary artery thermodilution at every
measurement point during the intraoperative and the post-
operative observation period. This finding indicates an
overestimation of CO by all continuous measurement tech-
niques. Agreement for all devices decreased early after the
intervention (T3–4).
Discussion
In the present study, we tested a new pulse wave analysis
device and two established systems for continuous CO
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monitoring and compared these with the clinical standard,
intermittent pulmonary artery thermodilution, in patients
with preserved left ventricular function undergoing elec-
tive cardiac surgery. The results show that the
performance of the FloTrac/VigileoTM system, the
PiCCOplusTM system, and continuous CO monitoring by
PAC were comparable.
Both the FloTrac/VigileoTM and the PiCCOplusTM
system are based on pulse pressure analysis. They calcu-
late the flow from the arterial pressure waveform, which is
itself the result of an interaction between the SV and the
elastic properties of the systemic vascular system. Thus,
resistance, compliance, and impedance at the site of the
signal detection must be considered. The FloTrac/
VigileoTM system calculates CO by the analysis of the
impact of vascular tone on pressure and adjustment for
actual vascular tone based on waveform analysis and
patient characteristics. In contrast to other available pulse
contour techniques,10 20 the system does not require an
external reference method for calibration or subsequent
correction. Therefore, it minimizes operator dependency
and its automatic adjustment for the changes of vascular
tone may eliminate drift phenomena.
Recently published studies investigating the FloTrac/
VigileoTM system showed inconsistent results.12 – 15
Manecke and Auger12 reported a mean bias of 0.55 (limits
of agreement 1.96) litre min21 between the FloTrac/
VigileoTM device and the intermittent pulmonary artery
thermodilution in 50 patients studied after cardiac surgery.
Opdam and colleagues14 reported data from 251 measure-
ments in six patients. Unfortunately, 66% of all measure-
ments were done in only one patient. Therefore, their
results are difficult to interpret. Sander and colleagues15
observed an overall bias of 0.6 (limits of agreement 2.8)
litre min21 between the FloTrac/VigileoTM system and
intermittent thermodilution in 30 cardiac surgery patients.
Most recently, another study performed in 40 patients in a
similar setting revealed a large mean bias of 0.46 (limits
of agreement 1.15) litre min21m22.13 In our study, in con-
trast, better results for the FloTrac/VigileoTM system were
found in terms of a smaller bias or smaller limits of agree-
ment for all measurements. These findings may be
explained by the fact that the software has been modified
recently. In order to better reflect the actual vascular status
of the patient, the time window for vascular adjustment
has been reduced from 10 to 1 min. Therefore, haemo-
dynamic changes before the measurement periods—even
under conditions of haemodynamic stability (i.e. after ster-
notomy)—may have had a larger impact on measurements
in the studies performed by Sander and colleagues15 or
Mayer and colleagues.13
Overall bias and limits of agreement for the
PiCCOplusTM system obtained in this study correspond to
the data of previously published work.8 – 11 In contrast to
the FloTrac/VigileoTM system, this system uses transpul-
monary thermodilution for calibration. Inaccurate
measurements as a result of variations in systemic vascu-
lar resistance were observed when the initial algorithm
was used.21 However, after the modification of the
algorithm to better address the individual patient’s aortic
compliance, the majority of studies found a good agree-
ment between the PiCCOplusTM values and the intermit-
tent thermodilution.8 10 11 The modified algorithm also
appears to be more robust in the situations of haemo-
dynamic changes.9 Interestingly, recent studies evaluating
this system in cardiac surgery patients revealed reliable
measurements before cardiopulmonary bypass, but less
accurate results if no recalibration was performed
early after cardiopulmonary bypass.22 23 In this period of
surgery, temperature and fluid shifts and changes of vas-
cular tone occur,24 and early recalibration has been
suggested to improve performance.23 Despite the early
recalibration in our study, we still observed a decreased
agreement between the PiCCOplusTM system and the
reference method in the postoperative period. This finding
may be related to an increase in signal-to-noise ratio of
Table 1 Haemodynamics during the study period. T1¼after induction of anaesthesia, T2¼after sternotomy, T3¼at skin closure, T4¼after transfer to the ICU,
T5–6¼during ICU stay hours 12 and 24 after study initiation. HR, heart rate; MAP, mean arterial pressure; MPAP, mean pulmonary artery pressure; CVP,
central venous pressure; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; CO, cardiac output; FCO, CO assessed by the FloTrac/
VigileoTM device; PCO, CO assessed by the PiCCOplusTM system; CCO, continuous CO measured by PAC using the VigilanceTM monitoring; ICO, CO
determined by the intermittent pulmonary artery thermodilution. Data are presented as mean(SD). *P,0.05 compared with ICO, **P,0.05 compared with T1,
***P,0.05 compared with T2 (all comparisons with T3 and T4 not significant)
Intraoperative measurements Postoperative measurements
T1 T2 T3 T4 T5 T6
FCO (litre min21) 4.7 (1.1)* 4.7 (0.9) 5.1 (0.9) 5.4 (1.2) 5.7 (1.1)**/*** 5.5 (1.2)***
PCO (litre min21) 4.7 (1.1)* 4.7 (1.2)* 5.3 (1.4) 5.5 (1.4) 5.8 (1.7)**/*** 5.4 (1.9)***
CCO(litre min21) 4.4 (1.2) 4.5 (1.2) 5.3 (1.6) 5.6 (1.6) 6.0 (1.5)**/*** 6.0 (1.6)**/***
ICO (litre min21) 4.2 (0.9) 4.3 (1.1) 5.0 (1.3) 5.3 (1.5) 5.6 (1.4)**/*** 5.6 (1.2)**/***
HR (beats min21) 64 (16) 67 (16) 82 (12)**/*** 89 (7)**/*** 88 (11)**/*** 77 (12)**/***
MAP (mm Hg) 76 (12) 74 (11) 72 (7) 72 (8) 72 (8) 77 (9)
MPAP (mm Hg) 25 (9) 24 (10) 24 (7) 24 (6) 24 (6) 24 (6)
CVP (mm Hg) 12 (4) 10 (4) 12 (3) 11 (4) 11 (4) 12 (4)
PCWP (mm Hg) 16 (6) 16 (4) 16 (4) 15 (5) 15 (5) 16 (12)
SVR (dyn s cm25) 1277 (276) 1252 (412) 1010 (251)*** 1012 (274)*** 921 (265)*** 961 (154)***
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transpulmonary thermodilution because of potential
thermal influences on this calibration technique after car-
diopulmonary bypass. Therefore, calibration by means of
thermodilution may not necessarily increase the accuracy
of a CO monitoring device. Although the PiCCOplusTM
system is considered a ‘less-invasive’ CO monitoring
device, measurements are typically derived via a femoral
catheter. Complications may occur, primarily ischaemia
or bleeding related to femoral artery puncture and
catheter use with an incidence up to 5%.25 One of our
patients enrolled in this study had a major bleeding com-
plication requiring surgical intervention after removal of
the PiCCOTM catheter.
Despite the development and the increased clinical use
of different less invasive devices in the last years, continu-
ous CO monitoring using the PAC remains the standard,
especially when monitoring of pulmonary artery pressures
is indicated. Corresponding to previous investigations,22 26
Fig 1 Bland–Altman analysis for CO measurements during the intraoperative period using the FloTrac/VigileoTM system, the PiCCOplusTM system,
and the PAC/VigilanceTM monitoring compared with the intermittent pulmonary artery thermodilution. T1¼after induction of anaesthesia, T2¼after
sternotomy, T3¼at skin closure; CO, cardiac output; FCO, CO by the FloTrac/VigileoTM device; PCO, CO by the PiCCOplusTM system; CCO,
continuous CO measured by PAC using the VigilanceTM monitoring; ICO, CO by intermittent pulmonary artery thermodilution (iced water bolus
method). Solid line, mean bias; dashed lines, limits of agreement.
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we found a closer agreement between continuous CO
monitoring and intermittent thermodilution in the pre-
intervention period than in the early postoperative period.
However, these changes of accuracy were less distinct than
that reported previously.
Some limitations and methodological aspects have to be
considered. The CO was assessed in low-risk cardiac sur-
gical patients and values obtained were in a narrow range.
Although the study revealed a comparable performance of
the continuous CO monitoring systems, large limits of
agreement were observed indicating that all continuous
monitoring systems studied have limitations as regards
their reliability and accuracy. Intermittent pulmonary
artery thermodilution was used as a reference method for
CO measurement. This technique is often referred to as
the clinical standard, but it has well-known pitfalls related
Fig 2 Bland–Altman analysis for CO measurements during the postoperative period using the FloTrac/VigileoTM system, the PiCCOplusTM system,
and the PAC/VigilanceTM monitoring compared with the intermittent pulmonary artery thermodilution. T4¼after transfer to the ICU, T5–6¼during
ICU stay; CO, cardiac output; FCO, CO by the FloTrac/VigileoTM device; PCO, CO by the PiCCOplusTM system; CCO, continuous CO measured by
PAC using the VigilanceTM monitoring; ICO, CO by intermittent pulmonary artery thermodilution (iced water bolus method). Solid line, mean bias;
dashed lines, limits of agreement.
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to operator variation, patient pathologies, and the indicator
used.27 While operator influences were minimized and
patient pathologies known to induce bias were excluded,
thermal influences in the postoperative period are likely to
have influenced our results. Techniques independent of
thermal influence or flow measurements as additional
reference methods would have been of interest in this
situation. Finally, Bland–Altman analysis is a widely
accepted method to compare two methods measuring the
same variable. However, it has often been applied in a mis-
leading manner. Initially designed to compare single
measurements,19 it is increasingly used to compare repeated
measurements. In such situations, an incorrect assumption is
made that measurements are independent. However, it may
be used for repeated measurements to calculate separate
values and draw separate figures for each time point.
In conclusion, the performance of all continuous CO
measurement devices, i.e. the FloTrac/VigileoTM and the
PiCCOplus systemTM, and continuous monitoring by PAC,
was comparable in patients undergoing elective cardiac
surgery. However, limitations regarding the reliability of
all continuous cardiac techniques in this clinical situation
should be borne in mind.
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